美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA203719"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
63323-982-54 63323-982 HUMAN PRESCRIPTION DRUG Piperacillin and Tazobactam Piperacillin and Tazobactam INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20180518 N/A ANDA ANDA203719 Fresenius Kabi USA, LLC PIPERACILLIN SODIUM; TAZOBACTAM SODIUM 4 g/20mL; .5 g/20mL 10 VIAL, SINGLE-USE in 1 CARTON (63323-982-54) / 20 mL in 1 VIAL, SINGLE-USE (63323-982-43)
63323-983-21 63323-983 HUMAN PRESCRIPTION DRUG Piperacillin and Tazobactam Piperacillin and Tazobactam INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20180518 N/A ANDA ANDA203719 Fresenius Kabi USA, LLC PIPERACILLIN SODIUM; TAZOBACTAM SODIUM 3 g/15mL; .375 g/15mL 10 VIAL, SINGLE-USE in 1 CARTON (63323-983-21) / 15 mL in 1 VIAL, SINGLE-USE (63323-983-23)
63323-983-53 63323-983 HUMAN PRESCRIPTION DRUG Piperacillin and Tazobactam Piperacillin and Tazobactam INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20180518 N/A ANDA ANDA203719 Fresenius Kabi USA, LLC PIPERACILLIN SODIUM; TAZOBACTAM SODIUM 3 g/15mL; .375 g/15mL 10 VIAL, SINGLE-USE in 1 CARTON (63323-983-53) / 15 mL in 1 VIAL, SINGLE-USE (63323-983-41)
63323-982-52 63323-982 HUMAN PRESCRIPTION DRUG Piperacillin and Tazobactam Piperacillin and Tazobactam INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20180518 N/A ANDA ANDA203719 Fresenius Kabi USA, LLC PIPERACILLIN SODIUM; TAZOBACTAM SODIUM 4 g/20mL; .5 g/20mL 10 VIAL, SINGLE-USE in 1 CARTON (63323-982-52) / 20 mL in 1 VIAL, SINGLE-USE (63323-982-21)
63323-981-53 63323-981 HUMAN PRESCRIPTION DRUG Piperacillin and Tazobactam Piperacillin and Tazobactam INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20180518 N/A ANDA ANDA203719 Fresenius Kabi USA, LLC PIPERACILLIN SODIUM; TAZOBACTAM SODIUM 2 g/10mL; .25 g/10mL 10 VIAL, SINGLE-USE in 1 CARTON (63323-981-53) / 10 mL in 1 VIAL, SINGLE-USE (63323-981-41)
63323-981-21 63323-981 HUMAN PRESCRIPTION DRUG Piperacillin and Tazobactam Piperacillin and Tazobactam INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20180518 N/A ANDA ANDA203719 Fresenius Kabi USA, LLC PIPERACILLIN SODIUM; TAZOBACTAM SODIUM 2 g/10mL; .25 g/10mL 10 VIAL, SINGLE-USE in 1 CARTON (63323-981-21) / 10 mL in 1 VIAL, SINGLE-USE (63323-981-23)
65219-259-55 65219-259 HUMAN PRESCRIPTION DRUG Piperacillin and Tazobactam Piperacillin and Tazobactam INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20210524 N/A ANDA ANDA203719 Fresenius Kabi USA, LLC PIPERACILLIN SODIUM; TAZOBACTAM SODIUM 4 g/20mL; .5 g/20mL 10 VIAL, SINGLE-USE in 1 CARTON (65219-259-55) / 20 mL in 1 VIAL, SINGLE-USE (65219-259-15)
65219-259-45 65219-259 HUMAN PRESCRIPTION DRUG Piperacillin and Tazobactam Piperacillin and Tazobactam INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20180518 N/A ANDA ANDA203719 Fresenius Kabi USA, LLC PIPERACILLIN SODIUM; TAZOBACTAM SODIUM 4 g/20mL; .5 g/20mL 10 VIAL, SINGLE-USE in 1 CARTON (65219-259-45) / 20 mL in 1 VIAL, SINGLE-USE (65219-259-05)
65219-434-20 65219-434 HUMAN PRESCRIPTION DRUG Piperacillin and Tazobactam Piperacillin and Tazobactam INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20230320 N/A ANDA ANDA203719 Fresenius Kabi USA, LLC PIPERACILLIN SODIUM; TAZOBACTAM SODIUM 2 g/10mL; .25 g/10mL 10 VIAL, SINGLE-DOSE in 1 CARTON (65219-434-20) / 10 mL in 1 VIAL, SINGLE-DOSE (65219-434-02)
65219-436-20 65219-436 HUMAN PRESCRIPTION DRUG Piperacillin and Tazobactam Piperacillin and Tazobactam INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20230320 N/A ANDA ANDA203719 Fresenius Kabi USA, LLC PIPERACILLIN SODIUM; TAZOBACTAM SODIUM 3 g/15mL; .375 g/15mL 10 VIAL, SINGLE-DOSE in 1 CARTON (65219-436-20) / 15 mL in 1 VIAL, SINGLE-DOSE (65219-436-02)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase